THIS!

After a big academic meeting like Digestive Disease Week , the energy is high—but don’t let the connections fade #DDW2025 10 practical ways to keep the momentum going & turn hallway convos into real opportunities 👇 ⚠️ Everyone follows up differently—don’t be discouraged by silence.

🗞️Big News: We’re thrilled to announce two travel grants ($1500 each) to attend Color of Gastrointestinal Illnesses's annual Equity in GI conference in Atlanta. One grant will be given to a patient with inflammatory bowel disease (IBD) and the other will be given to an ABGH member. The deadline is June

The U.S. FDA has approved semaglutide 2.4 mg for the treatment of adults with Metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis (F2–F3) in combination with a reduced calorie diet and increased physical activity. #MASH